Published:
Myriad Genetics Announces First Quarter Fiscal 2008 Financial Results Conference Call
Thursday, November 1, 2007 at 10:00 a.m. ET

Myriad Genetics, Inc. (NASDAQ: MYGN) has
arranged a conference call with the management team to provide a company
update. Peter D. Meldrum, President and Chief Executive Officer, will host
the call along with Jay M. Moyes, Chief Financial Officer; Gregory C.
Critchfield, M.D., President of Myriad Genetic Laboratories, Inc.; and
Adrian N. Hobden, Ph.D., President of Myriad Pharmaceuticals, Inc.
DATE: November 1, 2007
TIME: 10:00 am ET
DOMESTIC DIAL-IN: (888) 589-2820
INTERNATIONAL DIAL-IN: (706) 634-2173
CONFERENCE ID# 21783581
(Please dial in approximately 10 minutes before
the call is scheduled to begin)
A press release will be issued at 6:30 am ET on November 1, 2007.
Replay of the call will be available from two hours after the call for
seven days by dialing (800) 642-1687 or (706) 645-9291, and entering the
conference ID number.
A live audio Webcast will be available at: www.myriad.com
Copyright © 2009, MarketWire
Copyright © 2009, NewsBlaze,
Daily News
Tags: ,Pharmaceuticals and Biotech:Drugs, PharmaceuticalsandBiotech:Biotech, ,NASDAQ01,NASDAQ01,UT,SALT LAKE CITY, UT